Hob Biotech Group Stock Short Ratio
| 688656 Stock | 111.45 1.35 1.23% |
HOB Biotech Group fundamentals help investors to digest information that contributes to HOB Biotech's financial success or failures. It also enables traders to predict the movement of HOB Stock. The fundamental analysis module provides a way to measure HOB Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HOB Biotech stock.
HOB | Short Ratio |
HOB Biotech Group Company Short Ratio Analysis
HOB Biotech's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, HOB Biotech Group has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The short ratio for all China stocks is 100.0% higher than that of the company.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
HOB Fundamentals
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 6.95 B | ||||
| Shares Outstanding | 63.06 M | ||||
| Shares Owned By Insiders | 77.69 % | ||||
| Shares Owned By Institutions | 3.10 % | ||||
| Price To Book | 8.61 X | ||||
| Price To Sales | 17.44 X | ||||
| Revenue | 394.41 M | ||||
| Gross Profit | 320.16 M | ||||
| EBITDA | 78.62 M | ||||
| Net Income | 47.92 M | ||||
| Total Debt | 54.83 M | ||||
| Book Value Per Share | 12.95 X | ||||
| Cash Flow From Operations | 102.69 M | ||||
| Earnings Per Share | 0.56 X | ||||
| Number Of Employees | 550 | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 7 B | ||||
| Total Asset | 949.26 M | ||||
| Retained Earnings | 162.13 M | ||||
| Working Capital | 192.46 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 949.26 M | ||||
| Last Dividend Paid | 0.4 |
About HOB Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HOB Biotech Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HOB Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HOB Biotech Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.